Qing‐Tian Niu
Amgen (United States)(US)
Publications by Year
Research Areas
Bone Metabolism and Diseases, Bone health and osteoporosis research, Bone health and treatments, Osteoarthritis Treatment and Mechanisms, Regulation of Appetite and Obesity
Most-Cited Works
- → Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength(2008)937 cited
- → Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis(2008)778 cited
- → Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats(2010)234 cited
- → Tissue-Level Mechanisms Responsible for the Increase in Bone Formation and Bone Volume by Sclerostin Antibody(2013)165 cited
- → Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury(2011)120 cited
- → Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab(2015)117 cited
- → Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats(2014)97 cited
- → Increased Bone Formation and Bone Mass Induced by Sclerostin Antibody Is Not Affected by Pretreatment or Cotreatment with Alendronate in Osteopenic, Ovariectomized Rats(2011)88 cited
- → Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury(2012)84 cited
- → Progressive Increases in Bone Mass and Bone Strength in an Ovariectomized Rat Model of Osteoporosis After 26 Weeks of Treatment With a Sclerostin Antibody(2014)71 cited